FindTrial
Sign In

To check usefulness of purposefully limiting visualization of the opening of windpipe while putting tube through nose

Comparison of deliberately restricted glottic view with optimal glottic view during videolaryngoscope guided nasotracheal intubation: A randomised clinical trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030328
Enrollment
36
Registered
2021-01-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M26-M27- Dentofacial anomalies [including malocclusion] and other disorders of jaw Health Condition 2: S024- Fracture of malar, maxillary and zygoma bones Health Condition 3: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx

Interventions

Intervention1: Group R (restricted glottic view): Nasotracheal intubation will be done using videolaryngoscope with restricted glottic view and endotracheal tube cuff inflation technique. Restricted g
thereby intentionally limiting laryngoscopy to a grade 2 Cormack-Lehane view / less than 50% actual glottic opening visible (Percentage of glottic opening- POGO). Control Intervention1: Group O (optim

Sponsors

Post Graduate Institute of Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists physical status I and II patients undergoing surgeries under general anesthesia requiring nasotracheal intubation

Exclusion criteria

Exclusion criteria: 1. Known significant cardio-vascular, respiratory, nervous system dysfunction, 2. Patients with cervical instability, 3. Severe derangements of coagulation profile/ bleeding disorders, 4. Recurrent epistaxis, 5. Uncontrolled hypertension, 6. Known difficult airway, 7. Rapid sequence induction is required, 8. If attending anesthesiologists consider use of the videolaryngoscope to be contraindicated, 9. Upper respiratory tract infection within the previous 2 weeks, 10. Patientâ??s refusal to consent

Design outcomes

Primary

MeasureTime frame
Time to intubationTimepoint: During nasotracheal intubation—

Secondary

MeasureTime frame
Bleeding Timepoint: During nasotracheal intubation;First-attempt success rate Timepoint: During nasotracheal intubation;Grades of difficulty while passage of tracheal tube Timepoint: During nasotracheal intubation;Number of patients in whom Magill forceps is used Timepoint: During nasotracheal intubation;Overall success rate Timepoint: During nasotracheal intubation;Postoperative sore throat Timepoint: On postoperative day 1—

Countries

India

Contacts

Public ContactDevaki Kavya Sree

Post- Graduate Institute of Medical Education and Research

dr.komalgandhi@yahoo.com7087003376

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026